Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Revista Española de Enfermedades Digestivas
versión impresa ISSN 1130-0108
Rev. esp. enferm. dig. vol.105 no.10 Madrid nov./dic. 2013
https://dx.doi.org/10.4321/S1130-01082013001000014
LETTERS TO THE EDITOR
Adult hepatoblastoma: Case report with adrenal recurrence
Tratamiento del hepatoblastoma en adultos: a propósito de un caso con recidiva en la glándula adrenal
Key words: Hepatoblastoma. Liver cancer. Hepatic tumor.
Palabras clave: Hepatoblastoma. Cáncer hepático. Tumor hepático.
Dear Editor,
Hepatoblastoma is the most frequent primary liver tumor of childhood, with an annual incidence of 0.5-1.5 cases per million (1). It is very rare in adults, with a controversial existent since some authors believe that most of them are really underdiagnosed hepatocarcinomas, mixed sarcomas or hepatic cholangio-hepatocarcinomas. To date, there are only 40 reported cases of hepatoblastoma in adult patients. The first case was described by Barnett in 1958. (2) The only available treatment that has improved survival is radical surgery (R0). The main difference with children is the frequency of lymphatic or hematogenous metastases, which are extremely rare in the pediatric population (3,4).
Case report
We report the case of a 27-year-old male, born in Guinea, with chronic B hepatitis (HBsAg +, HBcAb +, HBeAb +, and HBeAg-), who was diagnosed with a large hepatic tumor of 17.2 x 15.3 x 22.2 cm replacing the entire right hepatic lobe. CT-scan showed a neoplasm with arterial contrast enhancement and, in the laboratory test, we found an alpha-fetoprotein of 1.166.000 ng/ml. Right hepatectomy extended to segment IV for a free resection margin (R0) was performed. It was a solid and yellowish tumor, with multinodular appearance and myxoid and necrotic areas. Histopathological study revealed the presence of a malignant primary liver tumor with features suggesting a mixed hepatoblastoma with fetal and embryonic areas. The immunohistochemical study confirmed the diagnosis. The patient received adjuvant chemotherapy according to SIOPEL 4. After 15 months follow-up, a PET-CT detected the presence of left adrenal recurrence. Total adrenalectomy was performed with complete resection of the tumor (R0). After 12 months follow-up of the second surgery, the patient has no further signs of recurrence.
Discussion
Adult hepatoblastoma has higher risk of metastases, synchronous or metachronous, that children hepatoblastoma (5). This is the second case reported in the literature that describes an adrenal recurrence after hepatoblastoma resection (6). The experience in the treatment of hepatoblastoma metastases is poor, and there are not well-defined protocols. To date, radical surgery (R0) of the metastases seems to be the only available curative treatment (7,8).
Hepatoblastoma is a typical tumor from children. Although some authors question the existence in adults, several cases have been reported in the literature. The prognosis is generally poor and the only available treatment is radical surgery (R0), both the primary tumor and metastases.
Óscar Caso-Maestro, Iago Justo-Alonso, Félix Cambra-Molero,
Alejandro Manrique-Municio, Jorge Calvo-Pulido and Carlos Jiménez-Romero
Departmen of General Surgery and Abdominal Organ Transplantations.
Hospital Universitario 12 de Octubre. Madrid, Spain
References
1. Rougemont AL, McLin VA, Toso C, Wildhaber BE. Adult hepatoblastoma: Learning from children. J Hepatol 2012;56:1392-403. [ Links ]
2. Barnett WH, Erickson EE, Halpert B. Embryogenic tumor of the liver in an adult. Cancer 1958;11:306-9. [ Links ]
3. Díaz-Faes M, Lamamie de Clairac E, Pozo F, Urdiales G, Valverde D, Sampedro A. Mixed hepatoblastoma in a an adult. Rev Esp Enferm Dig 1987;71:157-60. [ Links ]
4. Wang YX, Liu H. Adult hepatoblastoma: Systematic review of the English literature. Dig Surg 2012;29:323-30. [ Links ]
5. Schnater JM, Köhler SE, Lamers WH, von Schweinitz D, Aronson DC. Where do we stand with hepatoblastoma? A review. Cancer 2003;98:668-78. [ Links ]
6. Dumortier J, Bizollon T, Chevallier M, Ducerf C, Baulieux J, Scoazec JY, et al. Recurrence of hepatocellular carcinoma as a mixed hepatoblastoma after liver transplantation. Gut 1999;45:622-5. [ Links ]
7. De Loris M, Brugieres L, Zimmermann A, Keeling J, Brock P, Maibach R, et al. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: The SIOPEL group experience. Eur J Cancer 2008;44:545-50. [ Links ]
8. Nakamura S, Sho M, Kanehiro H, Tanaka T, Kichikawa K, Nakajima Y. Adult hepatoblastoma successfully treated with multimodal treatment. Langenbecks Arch Surg 2010;395:1165-8. [ Links ]